Shaily Engineering Plastics
2,623.10
+95.90(+3.79%)
Market Cap₹12,054.48 Cr
PE Ratio81.00
Company Performance:
1D+3.79%
1M+3.28%
6M+38.17%
1Y+137.99%
5Y+549.76%
View Company Insightsright
More news about Shaily Engineering Plastics
08Nov 25
Shaily Engineering Plastics Reports 14% Revenue Growth in Q2 FY2026
Shaily Engineering Plastics Limited announced impressive Q2 FY2026 results. Revenue from operations increased by 14% to ₹246.00 crore. Net profit after tax rose by 26.84% to ₹52.55 crore. Basic EPS grew by 26.83% to ₹11.44. For the half-year, consolidated revenue reached ₹492.01 crore, up 16.23% year-over-year. The Board of Directors approved these results on November 8, 2025.
31Oct 25
Shaily Engineering Plastics Grants USD 1 Million Unsecured Loan to Dubai Subsidiary
Shaily Engineering Plastics Limited (SEPL) has provided an unsecured loan of up to $1 million to its wholly owned subsidiary, Shaily Innovations FZCO in Dubai, UAE. The loan, with an 8% annual interest rate and a maximum tenure of 10 years, is intended for capital expenditure, business development, and operational expenses. This strategic move aims to support the subsidiary's initial operations and strengthen SEPL's presence in the Middle East region. The transaction, classified as a related party deal, complies with regulatory requirements and has been disclosed to stock exchanges in line with SEBI regulations.
30Oct 25
Shaily Engineering Plastics Shares Plunge 13% Amid Dr. Reddy's Semaglutide Approval Delay
Shaily Engineering Plastics experienced a 13% stock drop, its worst since May 2022, due to delayed Canadian approval for Dr. Reddy's Semaglutide injection. Dr. Reddy's, a key client, contributes to 31% of Shaily's revenue in healthcare. Despite the setback, Shaily has expanded healthcare capabilities with 19 injection molding machines and plans for additional capacity. The company claims a 60% share in the generic Semaglutide market across opening markets. Despite the recent drop, Shaily's stock has gained over 65% overall.
07Oct 25
ADIA and Institutional Investors Acquire 2.9% Stake in Shaily Engineering Plastics
A group of prominent institutional investors, including Abu Dhabi Investment Authority (ADIA), collectively acquired a 2.9% stake (13,33,155 shares) in Shaily Engineering Plastics for ₹284.00 crore at an average price of ₹2,134.00 per share. The shares were sold by Lighthouse Funds, reducing their holding from 4.27% to 1.37%. Other buyers include Motilal Oswal Mutual Fund, BofA Securities, and Societe Generale. The market responded positively with the stock price rising 11.91% to close at ₹2,408.15 on the BSE.
07Oct 25
Shaily Engineering Plastics Surges 7% Amid Strong Performance Streak
Shaily Engineering Plastics Ltd. (SEPL) shares rose over 7% to Rs 2,324.00, continuing a positive trend. The stock has shown impressive returns: 3.26% in 1 month, 40.42% in 3 months, 53.90% in 6 months, and 142.84% in 12 months. SEPL, India's largest plastic components exporter, has 2,000+ employees, 7 manufacturing units, and 200+ injection molding machines. Trading volume spiked 45 times the 30-day average, with RSI at 56. Of four analysts covering the stock, two recommend 'buy' and two suggest 'hold', with a 3.7% average upside potential.
18Aug 25
Shaily Engineering Plastics Reports Robust Q1 FY26 Results with 38% Revenue Growth
Shaily Engineering Plastics Limited (SEPL) reported impressive Q1 FY26 results with revenue up 38% to ₹246.70 crores, EBITDA up 95% to ₹70.40 crores, and PAT up 136% to ₹41.10 crores. The healthcare segment, particularly GLP-1 pen devices, was a key growth driver, with segment revenue soaring 181% to ₹77.20 crores. SEPL has commenced commercial manufacturing of GLP-1 pens for semaglutide and is expanding capacity with planned capex of ₹125.00 crores in FY26. The company expects continued growth in the healthcare segment and is in discussions with customers for future volume commitments.
11Aug 25
Shaily Engineering Plastics Reports Q1 Results, Re-appoints Whole-time Director
Shaily Engineering Plastics Limited (SEPL) reported robust Q1 financial results. Standalone revenue from operations reached ₹20,328.41 lakhs with a net profit of ₹2,376.10 lakhs. Consolidated revenue stood at ₹24,669.27 lakhs with a net profit of ₹4,112.27 lakhs. The company announced the re-appointment of Mrs. Tilottama Sanghvi as Whole-time Director, set a dividend record date, and approved a revised Code of Conduct for Prevention of Insider Trading. SEPL also invested AED 100,000 in its Dubai subsidiary, Shaily Innovations FZCO, to boost international presence.
25Jun 25
Shaily Engineering Plastics Soars 300% Since Listing, Reports Strong Q4 Results
Shaily Engineering Plastics Ltd. (SEPL) has seen its shares rise over 300% since its IPO two years ago, establishing itself as a multibagger stock. The company reported robust Q4 results with revenue growth of 27.7% and net profit increase of 47.9% year-on-year. Renowned investor Ashish Kacholia holds a 3.22% stake in SEPL. The company specializes in manufacturing high-precision injection molded plastic components for various industries including home furnishings, automotive, FMCG, and healthcare sectors.
13May 25
Shaily Engineering Plastics Reports Robust Q4 Results and Announces Dividend
Shaily Engineering Plastics Ltd. has announced impressive Q4 FY2023 results, with revenue up 29.41% to ₹2,200.00 crore, EBITDA increasing 57.06% to ₹545.00 crore, and net profit growing 48.19% to ₹286.00 crore year-over-year. The company's EBITDA margin expanded by 468 basis points to 25.02%. Additionally, a dividend of ₹2 per equity share has been recommended.
Shaily Engineering Plastics
2,623.10
+95.90
(+3.79%)
1 Year Returns:+137.99%
Industry Peers
Supreme Industries
3,463.90
(+1.07%)
Astral
1,466.00
(+0.03%)
Finolex Industries
184.51
(-0.33%)
Time Technoplast
202.70
(+1.39%)
Garware Hi-Tech Films
3,912.40
(+2.71%)
Jai Corp
143.01
(+1.10%)